Delving into the Latest Updates on Jiangsu Simiao Pharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Nervous System Diseases

Congenital Disorders

Immune System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Infectious Diseases	1
Immune System Diseases	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

COX(Cyclooxygenases)	1

Main study objectives: To evaluate the pharmacokinetic (PK) characteristics of diclofenac sodium for injection in healthy Chinese adult subjects after multiple intravenous injections of different doses. Secondary study objectives: To preliminarily evaluate the safety of diclofenac sodium for injection in healthy Chinese adult subjects after multiple intravenous injections of different doses.

Start Date-

Sponsor / Collaborator

Jiangsu Simiao Pharmaceutical Technology Co., Ltd.

CTR20210662

/ CompletedPhase 1

一项评估不同剂量注射用双氯芬酸钠在健康成年受试者中单次静脉推注的耐受性、安全性及药代动力学特征的单中心、双盲、随机、安慰剂平行对照Ia期临床研究

[Translation] A single-center, double-blind, randomized, placebo-controlled phase Ia clinical study to evaluate the tolerability, safety and pharmacokinetic characteristics of a single intravenous bolus of different doses of diclofenac sodium for injection in healthy adult subjects

主要目的：？初步评价单次静脉推注不同剂量注射用双氯芬酸钠后健康成年受试者的耐受性和安全性。次要目的：评价单次静脉推注不同剂量的注射用双氯芬酸钠在健康成年受试者体内的药代动力学（PK）特征。

[Translation]

Primary objective: ? To preliminarily evaluate the tolerability and safety of different doses of diclofenac sodium for injection in healthy adult subjects after a single intravenous push. Secondary objective: To evaluate the pharmacokinetic (PK) characteristics of different doses of diclofenac sodium for injection in healthy adult subjects after a single intravenous push.

Start Date01 Apr 2021

Sponsor / Collaborator

Jiangsu Simiao Pharmaceutical Technology Co., Ltd.

100 Clinical Results associated with Jiangsu Simiao Pharmaceutical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Jiangsu Simiao Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Deals associated with Jiangsu Simiao Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Jiangsu Simiao Pharmaceutical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data